Cure My Disease

Don't miss your cure!

 Log in / Sign up

New psoriasis pill shows promise in Skin-Clearing trial

NCT ID NCT06073119

Completed Disease control Sponsor: Sanofi Source: ClinicalTrials.gov ↗

Summary

This study tested a new oral medication called SAR441566 to see if it could safely reduce the skin plaques and redness of moderate to severe psoriasis. Over 200 adults with the condition took different doses of the drug or a placebo pill for 12 weeks. Researchers measured how much the participants' skin improved and monitored for any side effects.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PSORIASIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Center for Clinical Studies, LTD, LLP- Site Number : 8400013

    Webster, Texas, 77598, United States

  • Center for Clinical Studies, LTD. LLP- Site Number : 8400007

    Houston, Texas, 77004, United States

  • Daxia Trials Site Number : 8400022

    Boca Raton, Florida, 33431, United States

  • Dermatology Research Associates- Site Number : 8400019

    Los Angeles, California, 90045, United States

  • Direct Helpers Medical Center Inc- Site Number : 8400023

    Hialeah, Florida, 33012, United States

  • Driven Research, LLC- Site Number : 8400012

    Coral Gables, Florida, 33134, United States

  • FXM Clinical Research Ft. Lauderdale, LLC Site Number : 8400015

    Fort Lauderdale, Florida, 33308, United States

  • FXM Clinical Research Miami, LLC- Site Number : 8400016

    Miami, Florida, 33175, United States

  • Investigational Site Number : 0320001

    Buenos Aires, Buenos Aires F.D., 1060, Argentina

  • Investigational Site Number : 0320002

    CABA, Buenos Aires F.D., C1425DKG, Argentina

  • Investigational Site Number : 0320003

    CABA, Buenos Aires, C1023AAB, Argentina

  • Investigational Site Number : 1000001

    Sofia, 1404, Bulgaria

  • Investigational Site Number : 1240002

    Waterloo, Ontario, N2J 1C4, Canada

  • Investigational Site Number : 1240006

    London, Ontario, N6H 5L5, Canada

  • Investigational Site Number : 1520001

    Santiago, Reg Metropolitana de Santiago, 7640881, Chile

  • Investigational Site Number : 1520002

    Santiago, Reg Metropolitana de Santiago, 8420383, Chile

  • Investigational Site Number : 1520003

    Santiago, Reg Metropolitana de Santiago, 7580206, Chile

  • Investigational Site Number : 1520004

    Santiago, Reg Metropolitana de Santiago, 8330034, Chile

  • Investigational Site Number : 1560001

    Hangzhou, 310009, China

  • Investigational Site Number : 1560002

    Wuxi, 610017, China

  • Investigational Site Number : 2030003

    Brno, 602 00, Czechia

  • Investigational Site Number : 2680001

    Tbilisi, 0179, Georgia

  • Investigational Site Number : 2680002

    Batumi, 6000, Georgia

  • Investigational Site Number : 2760001

    Frankfurt am Main, 60590, Germany

  • Investigational Site Number : 2760002

    Witten, 58453, Germany

  • Investigational Site Number : 2760004

    Blankenfelde-Mahlow, 15827, Germany

  • Investigational Site Number : 3480002

    Debrecen, 4032, Hungary

  • Investigational Site Number : 3480003

    Budapest, 1083, Hungary

  • Investigational Site Number : 3920001

    Yokohama, 221-0825, Japan

  • Investigational Site Number : 3920002

    Tachikawa-shi, Tokyo, 190-0023, Japan

  • Investigational Site Number : 3920003

    Sakai-shi, Osaka, 593-8324, Japan

  • Investigational Site Number : 3920004

    Kamimashiki Gun, Kumamoto, 861-3106, Japan

  • Investigational Site Number : 3920005

    Ichikawa-shi, 272-0033, Japan

  • Investigational Site Number : 3920006

    Itabashi-ku, Tokyo, 173-8610, Japan

  • Investigational Site Number : 4800001

    Quatre Bornes, 72218, Mauritius

  • Investigational Site Number : 6160001

    Bydgoszcz, 85-796, Poland

  • Investigational Site Number : 6160002

    Katowice, 40-081, Poland

  • Investigational Site Number : 6200001

    Lisbon, 1998-018, Portugal

  • Investigational Site Number : 6200002

    Lisbon, 1649-035, Portugal

  • Investigational Site Number : 6200003

    Guimarães, 4810-061, Portugal

  • Investigational Site Number : 7240002

    Zaragoza, 50009, Spain

  • Investigational Site Number : 7240003

    Manises, Valencia, 46940, Spain

  • Investigational Site Number : 7240004

    Madrid, 28041, Spain

  • Investigational Site Number : 7240005

    Madrid, 28040, Spain

  • Investigational Site Number : 7240007

    Alicante, 03010, Spain

  • Investigational Site Number : 7920001

    Kayseri, 38039, Turkey (Türkiye)

  • Investigational Site Number : 7920002

    Antalya, 07070, Turkey (Türkiye)

  • Investigational Site Number : 8260001

    Manchester, M23 9QZ, United Kingdom

  • Jordan Valley Dermatology Center- Site Number : 8400027

    South Jordan, Utah, 84095, United States

  • Renaissance Research and Medical Group, Inc- Site Number : 8400018

    Cape Coral, Florida, 33991, United States

  • Scottsdale Clinical Trials Site Number : 8400025

    Scottsdale, Arizona, 85260, United States

Conditions

Explore the condition pages connected to this study.

PSORIASIS